These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11862582)

  • 41. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension.
    Onodera T; Tamura T; Said S; McCune SA; Gerdes AM
    Hypertension; 1998 Oct; 32(4):753-7. PubMed ID: 9774375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myocardial expression and redistribution of GRKs in hypertensive hypertrophy and failure.
    Yi XP; Zhou J; Baker J; Wang X; Gerdes AM; Li F
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):13-23. PubMed ID: 15584034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of tissue angiotensin II in myocardial remodelling induced by mechanical stress.
    Yamazaki T; Yazaki Y
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S43-7; discussion S49-50. PubMed ID: 10076920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.
    Jia N; Okamoto H; Shimizu T; Chiba S; Matsui Y; Sugawara T; Akino M; Kitabatake A
    Hypertens Res; 2003 Sep; 26(9):737-42. PubMed ID: 14620930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eplerenone enhances cardioprotective effects of standard heart failure therapy through matricellular proteins in hypertensive heart failure.
    Muñoz-Pacheco P; Ortega-Hernández A; Caro-Vadillo A; Casanueva-Eliceiry S; Aragoncillo P; Egido J; Fernández-Cruz A; Gómez-Garre D
    J Hypertens; 2013 Nov; 31(11):2309-18; discussion 2319. PubMed ID: 24077250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
    Nagura J; Yamamoto M; Hui C; Yasuda S; Hachisu M; Konno F
    Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):229-35. PubMed ID: 8934613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR; Widdop RE
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats.
    Kamide K; Rakugi H; Higaki J; Okamura A; Nagai M; Moriguchi K; Ohishi M; Satoh N; Tuck ML; Ogihara T
    Am J Hypertens; 2002 Jan; 15(1 Pt 1):66-71. PubMed ID: 11824863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of spironolactone during an angiotensin II receptor blocker treatment on the left ventricular mass reduction in hypertensive patients with concentric left ventricular hypertrophy.
    Taniguchi I; Kawai M; Date T; Yoshida S; Seki S; Taniguchi M; Shimizu M; Mochizuki S
    Circ J; 2006 Aug; 70(8):995-1000. PubMed ID: 16864931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II antagonism and the heart: valsartan in left ventricular hypertrophy.
    Thürmann PA
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S33-6; discussion S41-3. PubMed ID: 10028952
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel angiotensin II-receptor antagonist, 606A, induces regression of cardiac hypertrophy, augments endothelium-dependent relaxation and improves renal function in stroke-prone spontaneously hypertensive rats.
    Hashimoto Y; Kurosawa Y; Minami K; Fushimi K; Narita H
    Jpn J Pharmacol; 1998 Feb; 76(2):185-92. PubMed ID: 9541281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telmisartan reduces mortality and left ventricular hypertrophy with sympathoinhibition in rats with hypertension and heart failure.
    Kishi T; Hirooka Y; Sunagawa K
    Am J Hypertens; 2014 Feb; 27(2):260-7. PubMed ID: 24096926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiotensin AT1 receptor-mediated attenuation of cardiac hypertrophy due to volume overload: involvement of endothelin.
    Ishiye M; Umemura K; Uematsu T; Nakashima M
    Eur J Pharmacol; 1995 Jun; 280(1):11-7. PubMed ID: 7498249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
    Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
    J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
    Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
    Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.